Correlation Between Zentalis Pharmaceuticals and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Sarepta Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Sarepta Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Sarepta Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Zentalis and Sarepta is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Sarepta Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Sarepta Therapeutics. In addition to that, Zentalis Pharmaceuticals is 4.27 times more volatile than Sarepta Therapeutics. It trades about -0.35 of its total potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest 12,409 in Sarepta Therapeutics on November 2, 2024 and sell it today you would lose (964.00) from holding Sarepta Therapeutics or give up 7.77% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Sarepta Therapeutics
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Sarepta Therapeutics |
Zentalis Pharmaceuticals and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Sarepta Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |